ExSight Ventures
Pre-seed → Series B
Their stated focus (public profile)
ExSight Ventures is an early-stage life sciences venture capital firm specializing exclusively in ophthalmic diagnostic and treatment solutions, investing in biotechnology, medical devices, pharmaceuticals, and software with ophthalmic applications. The firm is led by two retinal surgeons who leverage deep domain expertise and networks to identify and back breakthrough technologies for vision diseases. It targets pre-seed through Series B rounds, emphasizing capital efficiency and the eye's unique anatomic advantages as a proving ground for innovation. The strategy is concentrated and specialized, with diversification intended to be achieved across managers rather than within the portfolio.
Stages: Pre-seed → Series B
Sectors: Life sciences, Medtech
On file: 13 companies on record
Website: exsightventures.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.